Zoetis (ZTS) Change in Receivables (2014 - 2026)
Zoetis' (ZTS) quarterly Change in Receivables came in at $106.0 million in Q1 2026, up 130.43% year-on-year from $46.0 million in Q1 2025, and up 103.85% on a QoQ basis from $52.0 million in Q4 2025.
Zoetis (ZTS) Change in Receivables (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has 13 years of Change in Receivables data on file, last reported at $106.0 million in Q1 2026.
- On a quarterly basis, Change in Receivables rose 130.43% year-over-year to $106.0 million in Q1 2026; TTM through Mar 2026 was $296.0 million, a 211.58% increase from a year earlier, with the FY2025 full-year figure at $236.0 million, up 286.89% from the prior year.
- Change in Receivables for Q1 2026 stood at $106.0 million, up from $52.0 million in the prior quarter.
- Over the last five years, Change in Receivables for ZTS reached as high as $148.0 million in Q2 2025 and fell as low as -$73.0 million in Q4 2024.
- Historically, Change in Receivables has averaged $37.8 million across 5 years, with a median of $46.0 million in 2025.
- Across the five-year window, Change in Receivables sank 933.33% in 2022 and soared 283.33% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $17.0 million in 2022, then surged by 182.35% to $48.0 million in 2023, then sank by 252.08% to -$73.0 million in 2024, then soared by 171.23% to $52.0 million in 2025, then soared by 103.85% to $106.0 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $106.0 million in Q1 2026, $52.0 million in Q4 2025, and -$10.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -38.20 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.00 Mn |
| Mar 31, 2026 | 106.00 Mn |
| Dec 31, 2025 | 52.00 Mn |
| Dec 31, 2025 | 52.00 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Sep 30, 2025 | -10.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 48.00 Mn |
| Dec 31, 2023 | 48.00 Mn |